Annual ROA
-49.80%
-9.51%-23.60%
31 December 2023
Summary:
Nektar Therapeutics annual return on assets is currently -49.80%, with the most recent change of -9.51% (-23.60%) on 31 December 2023. During the last 3 years, it has fallen by -24.52% (-96.99%). NKTR annual ROA is now -197.17% below its all-time high of 51.25%, reached on 31 December 2018.NKTR ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-44.58%
-1.89%-4.43%
30 September 2024
Summary:
Nektar Therapeutics quarterly return on assets is currently -44.58%, with the most recent change of -1.89% (-4.43%) on 30 September 2024. Over the past year, it has increased by +4.53% (+9.22%). NKTR quarterly ROA is now -143.23% below its all-time high of 103.13%, reached on 30 June 2018.NKTR Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.6% | +9.2% |
3 y3 years | -97.0% | -28.7% |
5 y5 years | -197.2% | -124.7% |
NKTR ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -97.0% | at low | -28.7% | +15.8% |
5 y | 5 years | -197.2% | at low | -124.7% | +15.8% |
alltime | all time | -197.2% | at low | -143.2% | +15.8% |
Nektar Therapeutics ROA History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -44.58%(+4.4%) |
June 2024 | - | -42.69%(+11.3%) |
Mar 2024 | - | -38.35%(-27.6%) |
Dec 2023 | -49.80%(+23.6%) | -52.95%(+7.8%) |
Sept 2023 | - | -49.11%(+9.1%) |
June 2023 | - | -45.00%(-14.5%) |
Mar 2023 | - | -52.65%(+28.5%) |
Dec 2022 | -40.29%(+2.1%) | -40.96%(-8.7%) |
Sept 2022 | - | -44.86%(-3.4%) |
June 2022 | - | -46.43%(+18.1%) |
Mar 2022 | - | -39.32%(+1.5%) |
Dec 2021 | -39.45%(+56.1%) | -38.74%(+11.9%) |
Sept 2021 | - | -34.63%(+9.1%) |
June 2021 | - | -31.74%(+18.3%) |
Mar 2021 | - | -26.84%(+2.8%) |
Dec 2020 | -25.28%(+18.4%) | -26.12%(+7.7%) |
Sept 2020 | - | -24.26%(+9.0%) |
June 2020 | - | -22.25%(-1.1%) |
Mar 2020 | - | -22.49%(+7.0%) |
Dec 2019 | -21.35%(-141.7%) | -21.02%(+5.9%) |
Sept 2019 | - | -19.84%(+2.7%) |
June 2019 | - | -19.32%(-155.1%) |
Mar 2019 | - | 35.06%(-20.6%) |
Dec 2018 | 51.25%(-385.7%) | 44.14%(-27.2%) |
Sept 2018 | - | 60.63%(-41.2%) |
June 2018 | - | 103.13%(-515.7%) |
Mar 2018 | - | -24.81%(+36.7%) |
Dec 2017 | -17.94%(-37.6%) | -18.15%(-10.9%) |
Sept 2017 | - | -20.36%(-52.1%) |
June 2017 | - | -42.49%(+6.4%) |
Mar 2017 | - | -39.94%(+27.4%) |
Dec 2016 | -28.76%(+66.5%) | -31.36%(-11.8%) |
Sept 2016 | - | -35.54%(+28.6%) |
June 2016 | - | -27.64%(-1.5%) |
Mar 2016 | - | -28.07%(+62.2%) |
Dec 2015 | -17.27%(+40.3%) | -17.31%(+10.6%) |
Sept 2015 | - | -15.65%(-1313.2%) |
June 2015 | - | 1.29%(-76.5%) |
Mar 2015 | - | 5.48%(-147.1%) |
Dec 2014 | -12.31%(-64.6%) | -11.63%(-6.0%) |
Sept 2014 | - | -12.37%(-62.0%) |
June 2014 | - | -32.58%(-7.9%) |
Mar 2014 | - | -35.37%(-5.0%) |
Dec 2013 | -34.75%(+11.7%) | -37.23%(+1.6%) |
Sept 2013 | - | -36.64%(-3.1%) |
June 2013 | - | -37.82%(+16.0%) |
Mar 2013 | - | -32.60%(+14.1%) |
Dec 2012 | -31.12%(+31.0%) | -28.56%(+15.3%) |
Sept 2012 | - | -24.76%(+18.9%) |
June 2012 | - | -20.82%(-0.4%) |
Mar 2012 | - | -20.91%(-1.6%) |
Dec 2011 | -23.76%(+243.4%) | -21.26%(+8.8%) |
Sept 2011 | - | -19.54%(+10.4%) |
June 2011 | - | -17.70%(+46.5%) |
Mar 2011 | - | -12.08%(+70.6%) |
Dec 2010 | -6.92%(-61.7%) | -7.08%(+60.5%) |
Sept 2010 | - | -4.41%(-49.8%) |
June 2010 | - | -8.78%(-41.6%) |
Mar 2010 | - | -15.03%(-24.7%) |
Dec 2009 | -18.05% | -19.96%(+465.4%) |
Sept 2009 | - | -3.53%(-20.5%) |
Date | Annual | Quarterly |
---|---|---|
June 2009 | - | -4.44%(+0.9%) |
Mar 2009 | - | -4.40%(-20.4%) |
Dec 2008 | -5.34%(+21.6%) | -5.53%(-49.6%) |
Sept 2008 | - | -10.97%(+39.9%) |
June 2008 | - | -7.84%(+15.6%) |
Mar 2008 | - | -6.78%(+51.0%) |
Dec 2007 | -4.39%(-76.9%) | -4.49%(-69.9%) |
Sept 2007 | - | -14.90%(+1.5%) |
June 2007 | - | -14.68%(-21.3%) |
Mar 2007 | - | -18.65%(-1.5%) |
Dec 2006 | -19.03%(-17.6%) | -18.94%(-27.9%) |
Sept 2006 | - | -26.28%(-4.1%) |
June 2006 | - | -27.39%(+15.5%) |
Mar 2006 | - | -23.72%(+1.5%) |
Dec 2005 | -23.09%(+54.3%) | -23.38%(+86.9%) |
Sept 2005 | - | -12.51%(-1.4%) |
June 2005 | - | -12.69%(+8.0%) |
Mar 2005 | - | -11.75%(-15.8%) |
Dec 2004 | -14.96%(+96.1%) | -13.95%(+24.8%) |
Sept 2004 | - | -11.18%(+1.2%) |
June 2004 | - | -11.05%(+7.2%) |
Mar 2004 | - | -10.31%(+34.9%) |
Dec 2003 | -7.63%(-54.8%) | -7.64%(-42.4%) |
Sept 2003 | - | -13.26%(-9.5%) |
June 2003 | - | -14.66%(-10.2%) |
Mar 2003 | - | -16.33%(-1.6%) |
Dec 2002 | -16.87%(-56.3%) | -16.59%(-2.3%) |
Sept 2002 | - | -16.98%(+2.5%) |
June 2002 | - | -16.56%(-41.2%) |
Mar 2002 | - | -28.17%(-23.6%) |
Dec 2001 | -38.56%(+69.5%) | -36.85%(-8.5%) |
Sept 2001 | - | -40.28%(-2.7%) |
June 2001 | - | -41.41%(+45.0%) |
Mar 2001 | - | -28.56%(+26.7%) |
Dec 2000 | -22.75%(+6.9%) | -22.55%(-4.4%) |
Sept 2000 | - | -23.60%(-10.7%) |
June 2000 | - | -26.42%(-10.1%) |
Mar 2000 | - | -29.39%(+13.5%) |
Dec 1999 | -21.28%(+47.4%) | -25.90%(+30.0%) |
Sept 1999 | - | -19.93%(+6.9%) |
June 1999 | - | -18.65%(+13.7%) |
Mar 1999 | - | -16.40%(+3.8%) |
Dec 1998 | -14.44%(+16.6%) | -15.80%(+9.9%) |
Sept 1998 | - | -14.38%(+12.3%) |
June 1998 | - | -12.81%(-3.3%) |
Mar 1998 | - | -13.25%(+1.9%) |
Dec 1997 | -12.38%(-59.9%) | -13.00%(-24.7%) |
Sept 1997 | - | -17.27%(-8.9%) |
June 1997 | - | -18.96%(-21.8%) |
Mar 1997 | - | -24.25%(-22.5%) |
Dec 1996 | -30.91%(-18.9%) | -31.29%(+0.7%) |
Sept 1996 | - | -31.06%(-0.3%) |
June 1996 | - | -31.16%(+3.5%) |
Mar 1996 | - | -30.10%(-6.9%) |
Dec 1995 | -38.12%(+23.7%) | -32.34%(-2.4%) |
Sept 1995 | - | -33.14%(+7.6%) |
June 1995 | - | -30.81%(-8.1%) |
Mar 1995 | - | -33.51%(+5.5%) |
Dec 1994 | -30.81% | -31.76%(+76.3%) |
Sept 1994 | - | -18.01%(+26.0%) |
June 1994 | - | -14.29%(-7.7%) |
Mar 1994 | - | -15.49% |
FAQ
- What is Nektar Therapeutics annual return on assets?
- What is the all time high annual ROA for Nektar Therapeutics?
- What is Nektar Therapeutics annual ROA year-on-year change?
- What is Nektar Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly ROA year-on-year change?
What is Nektar Therapeutics annual return on assets?
The current annual ROA of NKTR is -49.80%
What is the all time high annual ROA for Nektar Therapeutics?
Nektar Therapeutics all-time high annual return on assets is 51.25%
What is Nektar Therapeutics annual ROA year-on-year change?
Over the past year, NKTR annual return on assets has changed by -9.51% (-23.60%)
What is Nektar Therapeutics quarterly return on assets?
The current quarterly ROA of NKTR is -44.58%
What is the all time high quarterly ROA for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly return on assets is 103.13%
What is Nektar Therapeutics quarterly ROA year-on-year change?
Over the past year, NKTR quarterly return on assets has changed by +4.53% (+9.22%)